Cocrystal Pharma COCP
NASDAQ COCP
$1.16 +0.02 (+1.75%)
At close: Oct 2, 2026 · 4:00 PM EDT

Cocrystal Pharma (COCP) Liabilities from Discontinued Operations (2012 - 2013)

Updated

Cocrystal Pharma's Liabilities from Discontinued Operations came in at $3.92 million for Q4 2013, down 49.0% from $7.67 million a year earlier.

Analysis

Cocrystal Pharma (COCP) Liabilities from Discontinued Operations (2012 - 2013) Analysis & Trends

  • Going back by year, Liabilities from Discontinued Operations was $7.67 million in FY2012.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,082.65 Bn 1,051.23 Bn 19.71 Bn
2 Johnson & Johnson 623.68 Bn 542.21 Bn 17.26 Bn
3 AbbVie 459.43 Bn 432.59 Bn 12.70 Bn
4 Merck 354.80 Bn 309.23 Bn 12.21 Bn
5 Novartis Ag 269.16 Bn 225.03 Bn 11.24 Bn
6 Astrazeneca 244.40 Bn 217.97 Bn 12.86 Bn
7 Amgen 220.17 Bn 175.57 Bn 7.24 Bn
8 Gilead Sciences 183.05 Bn 157.16 Bn 6.22 Bn
9 Pfizer 160.27 Bn 107.22 Bn 10.94 Bn
10 Cocrystal Pharma 15.72 Mn -6.19 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2013 3.92 Mn
Dec 31, 2012 7.67 Mn
API Access

Cocrystal Pharma Liabilities from Discontinued Operations API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=liabilities-from-discontinued-operations&ticker=COCP&period=max&api_key=YOUR_API_KEY